Biotron (ASX:BIT) Accounts Payable & Accrued Expense : A$0.19 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Biotron Accounts Payable & Accrued Expense?

Biotron's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$0.35 Mil) to Jun. 2023 (A$0.53 Mil) but then declined from Jun. 2023 (A$0.53 Mil) to Dec. 2023 (A$0.19 Mil).

Biotron's annual accounts payable & accrued expense increased from Jun. 2022 (A$0.39 Mil) to Jun. 2023 (A$0.53 Mil) but then declined from Jun. 2023 (A$0.53 Mil) to Jun. 2024 (A$0.34 Mil).

Biotron Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biotron's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron Accounts Payable & Accrued Expense Chart

Biotron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.56

0.19

0.39

0.53

0.34

Biotron Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.39	0.35	0.53	0.19	0.34

Biotron Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biotron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (ASX:BIT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BITRF:USA

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron Headlines

From GuruFocus

BlackRock Multi-Sector Income Trust's Dividend Analysis

By GuruFocus Research • 10-13-2023

BlackRock Announces Fiscal Year End Change for BlackRock Multi-Sector Income Trust (BIT)

By Business Wire Business Wire • 06-01-2023